Title:
METTL3 INHIBITOR AND COMPOSITION, AND APPLICATION OF SAME IN MEDICINE
Document Type and Number:
WIPO Patent Application WO/2023/151697
Kind Code:
A1
Abstract:
The present invention relates to a compound represented by general formula (I) or a stereoisomer, a tautomer, a deuterated substance, a solvate, a prodrug, a metabolite and a pharmaceutically acceptable salt or eutectic crystal thereof, an intermediate thereof, and a use of the compound in METTL3-related diseases such as cancer.
Inventors:
ZHANG CHEN (CN)
LEI MING (CN)
MOU TAO (CN)
YU YAN (CN)
TANG PINGMING (CN)
MENG YIFEI (CN)
WENG GUANGLIN (CN)
LI YAO (CN)
YAN PANGKE (CN)
LEI MING (CN)
MOU TAO (CN)
YU YAN (CN)
TANG PINGMING (CN)
MENG YIFEI (CN)
WENG GUANGLIN (CN)
LI YAO (CN)
YAN PANGKE (CN)
Application Number:
PCT/CN2023/076002
Publication Date:
August 17, 2023
Filing Date:
February 14, 2023
Export Citation:
Assignee:
SICHUAN HAISCO PHARMACEUTICAL CO LTD (CN)
International Classes:
A61K31/519; C07D487/04; A61P35/00; A61P35/02; C07D403/12; C07D417/12; C07D495/04
Domestic Patent References:
| WO2021111124A1 | 2021-06-10 | |||
| WO2021079196A2 | 2021-04-29 | |||
| WO2021081211A1 | 2021-04-29 |
Foreign References:
| CN113905787A | 2022-01-07 |
Attorney, Agent or Firm:
WU , FENG & ZHANG (CN)
Download PDF:
Previous Patent: COMMUNICATION METHOD, COMMUNICATION APPARATUS, AND SYSTEM
Next Patent: HANDPRINT ACQUISITION SYSTEM
Next Patent: HANDPRINT ACQUISITION SYSTEM